Sector: MedicalAffymetrix, Inc. (NASDAQ: AFFX)
Headlines
- Trading Overview for Sequenom Inc. Issued by StockPreacher.com
Nov 17, 2009 06:54 AM | AFFX, CLDA, ILMN, SQNM
- Biotech Takes It on the Chin in October
Nov 02, 2009 12:06 PM | AFFX, AMGN, BIIB, ILMN
- Developing Countries Sign up for Pharmacogenomics for Every Nation Initiative Using the Affymetrix DMET(TM) Plus Panel
Oct 27, 2009 09:00 AM | AFFX
- Affymetrix Reports Third Quarter 2009 Results
Oct 21, 2009 04:00 PM | AFFX
- The Children's Hospital of Philadelphia Uses IDBS to Improve Understanding of Childhood Diseases
Oct 21, 2009 09:01 AM | AFFX, ILMN
- Affymetrix Announces Major Genotyping Project With Kaiser Permanente and the University of California at San Francisco for NIH-Funded Epidemiology Study
Oct 14, 2009 09:05 AM | AFFX
- Affymetrix Launches New Platform for Next-Generation Genotyping
Oct 14, 2009 09:01 AM | AFFX
- VICL, DNDN, BKD, RINO, ASPM, IFLO, HITK, AFFX: Seven Bullish Healthcare Stocks
Oct 12, 2009 11:40 AM | AFFX, ASPM, BKD, DNDN, HITK, IFLO
- StockPreacher.com Issues Trading Outlook for Sequenom Inc.
Oct 12, 2009 06:51 AM | AFFX, BEC, ILMN, MYGN, SQNM
- Affymetrix to Host Conference Call on October 21, 2009 to Announce Third Quarter 2009 Results
Oct 07, 2009 09:00 AM | AFFX
- BioInformatics, LLC New Report - New Media Marketing Channels: Creating Effective Online Life Science Promotional Videos
Sep 10, 2009 12:54 PM | AFFX, HLCS
- The NIAID-Supported Pathogen Functional Genomics Resource Center at the J. Craig Venter Institute Offers New Affymetrix Array for Faster Identification of E. Coli and Shigella
Aug 05, 2009 09:11 AM | AFFX
- Affymetrix Reports Second Quarter 2009 Results
Jul 22, 2009 04:02 PM | AFFX
- Affymetrix Reports Second Quarter 2009 Results ; -- Company Reports Total Revenue of $81.6 Million and Net Income of $7.3 Million --
Jul 22, 2009 02:59 PM | AFFX, ISRG
- Affymetrix to Host Conference Call on July 22, 2009 to Announce Second Quarter 2009 Results
Jul 08, 2009 09:13 AM | AFFX
- Affymetrix to Webcast Annual Meeting of Shareholders
Jun 11, 2009 07:05 PM | AFFX
- Key Milestones to Improve Operating Leverage Achieved Ahead of Schedule
Jun 02, 2009 01:57 PM | AFFX
- Affymetrix, Inc. (AFFX) President and Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell
Jun 02, 2009 11:18 AM | AFFX, NDAQ
- Affymetrix Chief Medical Officer to speak at AAAS on Personalized Medicine
May 29, 2009 07:03 PM | AFFX
- Entrepreneur Magazine Picks Affymetrix as One of Top 100 Companies to Watch
May 28, 2009 09:18 AM | AFFX
- Form 4 DIEKMAN JOHN D For: Oct 09 (10K)
Oct 13, 2009 06:06 PM
- Form 4 DIEKMAN JOHN D For: Aug 04 (10K)
Sep 17, 2009 06:52 PM
- Form 4 AFFYMETRIX INC For: Aug 20 Filed by: RUNKEL JOHN F JR (10K)
Aug 21, 2009 07:34 PM
- Form 4 FODOR STEPHEN P A For: Aug 20 (10K)
Aug 21, 2009 07:32 PM
- Form 4 BATTY JOHN For: Aug 20 (10K)
Aug 21, 2009 07:31 PM
- Form 4 King Kevin M For: Aug 20 (10K)
Aug 21, 2009 07:30 PM
- Form 4 BATTY JOHN For: Jun 27 (10K)
Jun 29, 2009 05:44 PM
- Form 4 King Kevin M For: Jun 27 (10K)
Jun 29, 2009 05:41 PM
- Form 4 FODOR STEPHEN P A For: Jun 27 (10K)
Jun 29, 2009 05:41 PM
- Form 4 BATTY JOHN For: Jun 18 (10K)
Jun 19, 2009 06:52 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
AFFX
|
Compare to S&P
|
| YTD |
70.23 %
|
40.62 %
|
| 4 Weeks |
-42.68 %
|
-42.98 %
|
| 12 Weeks |
-37.62 %
|
-41.47 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 0.00 %
|
|
EPS Growth in Last Year: 23.53 %
|
|
Sales Growth in Last Quarter: -4.12 %
|
|
Sales Growth in Last Quarter: 3.99 %
|
|
